pharmacie et médicaments – Soutenabilité de la filière médicamenteuse anti cancer

This written question asks about the sustainability of the anti-cancer drug sector in France. It seeks information on current challenges and future prospects for ensuring access to these vital treatments. The question addresses the economic and healthcare implications of cancer drug availability, potentially affecting patients, pharmaceutical companies, and public health systems.